These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 36947428)

  • 1. Rational development of multicomponent mRNA vaccine candidates against mpox.
    Zhang RR; Wang ZJ; Zhu YL; Tang W; Zhou C; Zhao SQ; Wu M; Ming T; Deng YQ; Chen Q; Jin NY; Ye Q; Li X; Qin CF
    Emerg Microbes Infect; 2023 Dec; 12(1):2192815. PubMed ID: 36947428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation and comparison of immune responses induced by two Mpox mRNA vaccine candidates in mice.
    Yang X; Hu C; Yang X; Yang X; Hu X; Wang X; Liu C; Yuan Y; Du S; Wang PG; Lin J
    J Med Virol; 2023 Oct; 95(10):e29140. PubMed ID: 37800627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polyvalent mpox mRNA vaccines elicit robust immune responses and confer potent protection against vaccinia virus.
    Ye T; Zhou J; Guo C; Zhang K; Wang Y; Liu Y; Zhou J; Xie Y; Li E; Gong R; Zhang J; Chuai X; Chiu S
    Cell Rep; 2024 Jun; 43(6):114269. PubMed ID: 38787725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mpox virus mRNA-lipid nanoparticle vaccine candidates evoke antibody responses and drive protection against the Vaccinia virus challenge in mice.
    Xia H; He YR; Zhan XY; Zha GF
    Antiviral Res; 2023 Aug; 216():105668. PubMed ID: 37429529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Three neutralizing mAbs induced by MPXV A29L protein recognizing different epitopes act synergistically against orthopoxvirus.
    Li M; Ren Z; Wang Y; Jiang Y; Yang M; Li D; Chen J; Liang Z; Lin Y; Zeng Z; Xu R; Wang Y; Zhu L; Xiao W; Wu Q; Zhang B; Wan C; Yang Y; Wu B; Peng J; Zhao W; Shen C
    Emerg Microbes Infect; 2023 Dec; 12(2):2223669. PubMed ID: 37288876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multi-valent mRNA vaccines against monkeypox enveloped or mature viron surface antigens demonstrate robust immune response and neutralizing activity.
    Zhang N; Cheng X; Zhu Y; Mo O; Yu H; Zhu L; Zhang J; Kuang L; Gao Y; Cao R; Liang X; Wang H; Li H; Li S; Zhong W; Li X; Li X; Hao P
    Sci China Life Sci; 2023 Oct; 66(10):2329-2341. PubMed ID: 37300753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. mRNA vaccines encoding fusion proteins of monkeypox virus antigens protect mice from vaccinia virus challenge.
    Hou F; Zhang Y; Liu X; Murad YM; Xu J; Yu Z; Hua X; Song Y; Ding J; Huang H; Zhao R; Jia W; Yang X
    Nat Commun; 2023 Sep; 14(1):5925. PubMed ID: 37739969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An mpox virus mRNA-lipid nanoparticle vaccine confers protection against lethal orthopoxviral challenge.
    Freyn AW; Atyeo C; Earl PL; Americo JL; Chuang GY; Natarajan H; Frey TR; Gall JG; Moliva JI; Hunegnaw R; Asthagiri Arunkumar G; Ogega CO; Nasir A; Santos G; Levin RH; Meni A; Jorquera PA; Bennett H; Johnson JA; Durney MA; Stewart-Jones G; Hooper JW; Colpitts TM; Alter G; Sullivan NJ; Carfi A; Moss B
    Sci Transl Med; 2023 Oct; 15(716):eadg3540. PubMed ID: 37792954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant proteins A29L, M1R, A35R, and B6R vaccination protects mice from mpox virus challenge.
    Tang D; Liu X; Lu J; Fan H; Xu X; Sun K; Wang R; Li C; Dan D; Du H; Wang Z; Li X; Yang X
    Front Immunol; 2023; 14():1203410. PubMed ID: 37435062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Subunit Vaccine Candidate Composed of Mpox Virus A29L, M1R, A35R, and B6R Elicits Robust Immune Response in Mice.
    Yang X; Yang X; Du S; Hu C; Yang X; Wang X; Hu X; Rcheulishvili N; Wang PG; Lin J
    Vaccines (Basel); 2023 Aug; 11(9):. PubMed ID: 37766097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multivalent mRNA monkeypox virus vaccine (BNT166) protects mice and macaques from orthopoxvirus disease.
    Zuiani A; Dulberger CL; De Silva NS; Marquette M; Lu YJ; Palowitch GM; Dokic A; Sanchez-Velazquez R; Schlatterer K; Sarkar S; Kar S; Chawla B; Galeev A; Lindemann C; Rothenberg DA; Diao H; Walls AC; Addona TA; Mensa F; Vogel AB; Stuart LM; van der Most R; Srouji JR; Türeci Ö; Gaynor RB; Şahin U; Poran A
    Cell; 2024 Mar; 187(6):1363-1373.e12. PubMed ID: 38366591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenic proteins and potential delivery platforms for mpox virus vaccine development: A rapid review.
    Wang Y; Yang K; Zhou H
    Int J Biol Macromol; 2023 Aug; 245():125515. PubMed ID: 37353117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid development of double-hit mRNA antibody cocktail against orthopoxviruses.
    Chi H; Zhao SQ; Chen RY; Suo XX; Zhang RR; Yang WH; Zhou DS; Fang M; Ying B; Deng YQ; Qin CF
    Signal Transduct Target Ther; 2024 Mar; 9(1):69. PubMed ID: 38531869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circular RNA vaccines against monkeypox virus provide potent protection against vaccinia virus infection in mice.
    Zhou J; Ye T; Yang Y; Li E; Zhang K; Wang Y; Chen S; Hu J; Zhang K; Liu F; Gong R; Chuai X; Wang Z; Chiu S
    Mol Ther; 2024 Jun; 32(6):1779-1789. PubMed ID: 38659224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross-reactive antibody response to Monkeypox virus surface proteins in a small proportion of individuals with and without Chinese smallpox vaccination history.
    Xia A; Wang X; He J; Wu W; Jiang W; Xue S; Zhang Q; Gao Y; Han Y; Li Y; Peng X; Xie M; Mayer CT; Liu J; Hua C; Sha Y; Xu W; Huang J; Ying T; Jiang S; Xie Y; Cai Q; Lu L; Silva IT; Yuan Z; Zhang Y; Wang Q
    BMC Biol; 2023 Oct; 21(1):205. PubMed ID: 37784185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two noncompeting human neutralizing antibodies targeting MPXV B6 show protective effects against orthopoxvirus infections.
    Zhao R; Wu L; Sun J; Liu D; Han P; Gao Y; Zhang Y; Xu Y; Qu X; Wang H; Chai Y; Chen Z; Gao GF; Wang Q
    Nat Commun; 2024 May; 15(1):4660. PubMed ID: 38821921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross-reactive immune responses to monkeypox virus induced by MVA vaccination in mice.
    Gao F; He C; Liu M; Yuan P; Tian S; Zheng M; Zhang L; Zhou X; Xu F; Luo J; Li X
    Virol J; 2023 Jun; 20(1):126. PubMed ID: 37337226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of binding and authentic virus-neutralizing activities of immune sera induced by various monkeypox virus antigens.
    Song S; Ren Z; Chen J; Li M; Jiang Y; Liu Y; Zhang B; Lu H; Zhao W; Shen C; Yang Y
    Immunol Res; 2024 Jun; ():. PubMed ID: 38829493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Duration of humoral immunity from smallpox vaccination and its cross-reaction with Mpox virus.
    Li E; Guo X; Hong D; Gong Q; Xie W; Li T; Wang J; Chuai X; Chiu S
    Signal Transduct Target Ther; 2023 Sep; 8(1):350. PubMed ID: 37709783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthetic modified vaccinia Ankara vaccines confer cross-reactive and protective immunity against mpox virus.
    Chiuppesi F; Zaia JA; Gutierrez-Franco MA; Ortega-Francisco S; Ly M; Kha M; Kim T; Dempsey S; Kar S; Grifoni A; Sette A; Wussow F; Diamond DJ
    Commun Med (Lond); 2024 Feb; 4(1):19. PubMed ID: 38366141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.